Olsson H - Search Results

1

Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brøndum-Nielsen K, Gerdes AM, Møller P, Kristoffersson U, Olsson H, Borg A, Monteiro AN. Vallon-Christersson J, et al. Among authors: olsson h. Hum Mol Genet. 2001 Feb 15;10(4):353-60. doi: 10.1093/hmg/10.4.353. Hum Mol Genet. 2001. PMID: 11157798 Free PMC article.

2

Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.

Borg A, Zhang QX, Olsson H, Wenngren E. Borg A, et al. Among authors: olsson h. Genes Chromosomes Cancer. 1992 Nov;5(4):311-20. doi: 10.1002/gcc.2870050406. Genes Chromosomes Cancer. 1992. PMID: 1283319

3

The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

Borg A, Zhang QX, Alm P, Olsson H, Sellberg G. Borg A, et al. Among authors: olsson h. Cancer Res. 1992 May 15;52(10):2991-4. Cancer Res. 1992. PMID: 1581913

4

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Among authors: olsson h. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

5

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: olsson h. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

6

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: olsson h. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

7

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.

Olsson H, Borg A, Fernö M, Möller TR, Ranstam J. Olsson H, et al. Cancer Detect Prev. 1991;15(4):265-71. Cancer Detect Prev. 1991. PMID: 1794133

8

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.

Olsson H, Borg A, Fernö M, Ranstam J, Sigurdsson H. Olsson H, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1483-7. doi: 10.1093/jnci/83.20.1483. J Natl Cancer Inst. 1991. PMID: 1920494

9

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Among authors: olsson h. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

10

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Among authors: olsson h. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

889 results

Search Page

Filters